BACKGROUND:
Saudi Arabia is a leading country in the Middle East in the field of deceased-donor liver trans--plantation (DDLT) and living-donor liver transplantation (LDLT). We present out experience with DDLT and LDLT at King Faisal Specialist Hospital and Research Center (KFSHRC) for the period from April 2001 to January 2007.
PATIENTS AND METHODS:
We performed 122 LT procedures (77 DDLTs and 45 LDLTs) in 118 patients (4 retransplants) during this period of time.
RESULTS:
The number of adult and pediatric procedures was 107 and 11, respectively. The overall male/female ratio was 66/52 and the median age of patients was 43 years (range, 2-63 years). In the DDLT group, the me--dian operating time was 8 hours (range, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , the median blood transfusion was 6 units (range, 0-40), and the median hospital stay was 13 days (range, 6-183). In the DDLT group, after a mean follow-up period of 760 days (range, 2-2085), the overall patient and graft survival rate was 86%. In the LDLT group, the median operating time was 11 hours (range, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , the median blood transfusion was 4 units (range, 0-65), and the median hospital stay was 15 days (range, 7-127). In the LDLT group, and after a mean follow-up period of 685 days (range, 26-1540), the overall patient and graft survival rates were 90% and 80%, respectively with no significant difference in patient and graft survivals between groups. Biliary complications were significantly higher in LDLT compared to DDLT (P<0.05). Vascular complications were also significantly higher in LDLT compared DDLT (P<0.05). CONCLUSIONS: Both DDLT and LDLT are being successfully performed at KFSHRC with early experience indicating a higher rate of biliary and vascular complications in the LDLT group.
was first established in 1994. At that time, 45 DDLTs were performed by a visiting LT team from abroad, but unfortunately that program was suspended in 1996 due to logistical difficulties ( Figure 1) . In April 2001, the LT program at KFSHRC was recstarted by a local team in an attempt to meet the rapidly growing need for LT in Saudi Arabia. 13 We present the KFSHRC experience in the last 6 years with both DDLT and LDLT.
PATIENT AND METHODS
In the period between April 2001 and January 2007 122 liver transplant procedures (77 DDLTs and 45 LDLTs) were performed in 118 patients (including 4 rectransplants) at KFSHRC. All 77 DDLTs procec c dures were performed by the local team using cadavc c eric organs retrieved from braincdead heartcbeating cadaveric donors who fulfilled the strict clinical criteria for brainstem death diagnosis set by the Saudi Center for Organ Transplantation. Almost all DDLT recipic c ents were adults; only 3 pediatric patients underwent DDLT. Double venocvenous bypass was used in six of the DDLT recipients. RouxcencY hepaticojejunostomy was used for biliary reconstruction in 12 DDLT recipic c ents while ductctocduct anastomosis was used in the remaining 65 DDLT recipients.
For the LDLT group, outside assistance was required in the first two LDLTs, while the local team alone withc c out outside assistance performed all the following 43 LDLT procedures. The left lateral segment (segments 2c3) was used in 8 pediatric LDLT recipients, the entire left lobe without the caudate (segments 2c4) was used in one pediatric LDLT recipient, and the whole right lobe (segments 5c8) was used in the 36 adult LDLT recipients. The middle hepatic vein was included with the right liver graft in only 3 LDLT recipients. In all LDLT procedures, microvascular surgeons performed the hepatic artery anastomosis using a microscope. RouxcencY hepaticojejunostomy (REY) was used for biliary reconstruction in 6 LDLT recipients, ductctoc duct anastomosis was used in 38, and combined REY and ductctocduct anastomoses were performed in one patient. All biliary anastomoses were performed using interrupted 6/0 absorbable sutures without stenting. Rectransplantation using a cadaveric organ was necesc c sary in 4 LDLT recipients.
All donors for LDLT were related to their recipients. The graftcrecipient weight ratios ranged from 0.8% to 1.7%; the remaining liver volume in all donors was ≥30% of the calculated whole liver volume; and macc c rovesicular steatosis in all grafts was ≤20% (estimated by routine percutaneous liver biopsy in all donors). All donors were carefully assessed and approved by a social worker, a psychologist, and at least one senior member of the surgical team.
Our postoperative immunosuppression regimen was mainly FK506 and steroids. Mycophenolate mofetil was used in conjunction with FK506 for various indications, including renal impairment, neurotoxicity, autoimmune etiology, and hepatitis C virus (HCV) recurrence. In most cases, steroids were stopped after 3 months, but continued in those with autoimmune etiology. A few patients were converted from calcineurin inhibitors to sirolimus for various reasons including nephrotoxicity, neurotoxicity, and posttransplant lymphoproliferative disorders. Lamivudine and hepatitis B virus (HBV) immunoglobulins were used in four patients who had HBV infectioncrelated cirrhosis.
A KaplancMeier analysis was used to measure the survival function, the logcrank test was used to compare between the survivals in different groups, and the Chic square test was used to compare the frequency of comc c plications in different groups. SPSS software was used for statistical analysis. A P value of < 0.05 was taken as significant.
RESULTS
The numbers of LTs performed per year is shown in Figure 2 . The overall male/female ratio was 66/52; the adult/pediatric ratio was 107/11, and the median age was 43 years (range, 2c63 years). Indications for liver transplantation in 122 LT recipients are shown in Table   1 . Liver cirrhosis due to viral hepatitis with or without hepatocellular carcinoma (HCC) was the main indicac c tion for LT in our study group (Figure 3 ). In the DDLT group, the male/female ratio was 38/39; the adult/pediatric ratio was 74/3; the medic c an age was 44 years (range, 11c63 years); the median operating time was 8 hours (range, 4c19), the median blood transfusion was 6 units (range, 0c40), and mec c dian hospital stay was 13 days (range, 6c183). The overc c all patient and graft survival rate was 86% after a mean followcup period of 760 days (range, 2c2085). The 11 deaths in the DDLT group were due to primary graft noncfunction in 4 patients, central pontine myelinolysis in one patient, recurrent hepatitis C virus cirrhosis in 3 patients, chronic rejection in one patient, recurrent HCC in one patient, and recurrent cholangiocarcinoma in one patient.
In the LDLT group, the male/female ratio was 29/16; the adult/pediatric ratio was 36/9; the median age was 47 years (range, 1.5c63 years); the median operc c ating time was 11 hours (range, 7c17), the median blood transfusion was 4 units (range, 0c65), and the median hospital stay was 15 days (range, 7c127). The overall pac c tient and graft survival rates were 90% and 80%, respecc c tively, after a mean followcup period of 685 days (range, 26c1540). Rectransplantation using cadaveric organ was necessary in 4 LDLT recipients. Graft failure and patient deaths were due to hepatic artery thrombosis in 2 cases, biliary complications in one patient, uncontrolc c lable bleeding in one patient, portal vein thrombosis in 2 cases, and smallcforcsize syndrome in 3 patients.
For the live liver donors, the male/female ratio was 34/11; the median age was 25 years (range, 18c42), the median hospital stay was 6 days (range, 4c14), and only two donors required intracoperative blood transfusion. After a median followcup period of 529 days (range, 8c 1354), a total of 28 morbidities were encountered in 17 donors (37.8%) of which 9 donors (20%) had serious complications (Table 2) . No donor death was encounc c tered in our experience.
Biliary complications were significantly higher in the LDLT group compared to the DDLT group-25.6% vs. 2.6% respectively (P<0.05). Vascular complications were also significantly higher in the LDLT group comc c pared with the DDLT group-8.9% vs. 2.6% respecc c tively (P<0.05).
The overall (DDLT and LDLT) patient and graft survival after a mean followcup period of 736 days (range, 6c2089) were 90% and 86%, respectively ( Figure  4) . The overall and actuarial survival rates in both DDLT and LDLT groups are summarized in Table  3 . In the shortcterm followcup there was significantly poorer graft survival rate in the LDLT (logcrank test, P<0.05); however, in longcterm followcup there was no statistical significant difference between the two groups in either patient survival or in graft survival (Figures 4c  6) . This can be simply explained by the use of cadaver organs to rectransplant failed LDLT grafts.
DiScUSSion
The Saudi Center for Organ Transplantation was succ c cessfully established in 1985, 14 and this paved the way for the launch of DDLT programs in our country. The first DDLT in Saudi Arabia was performed in 1990, and to date more than 300 of these operations have been performed with good success. 1 As mentioned, the LT program at KFSHRC lapsed for a period, and was reactivated by our current surgical team in 2001. We have since performed 77 DDLT procedures with excelc c lent outcomes and a survival rate that is comparable to rates at other experienced LT centers. However, soon after restarting our DDLT program, we were faced with the major barrier of a severe cadaveric organ shortage for LT in Saudi Arabia. This shortage is due to many complex logistical problems in all steps of the cadavc c eric donation process, including donor identification, reporting, diagnosis, management, documentation, and obtaining consent.
14c20 This distressing scarcity of cadaveric donor organs, together with the increasc c ing number of patients dying on our LT waiting list has significantly limited our ability to expand our LT program. Therefore, we were forced to consider adoptc c ing LDLT, which seemed the only logical way forward in our situation. Our initial reluctance to undertake LDLT was fueled by the many ethical questions that are generated by the concept of live liver donation: Is it ethical to ask a person to donate part of his or her liver to save the life of a loved one? Can the donor truly give informed consent under such circumstances? Would it not be considered "emotional blackmail"? Is it ethical to subject a healthy person to a major operation with poc c tential morbidity and mortality in order to save the life of another? Another major concern about live donation is the likelihood of organ trafficking, which cannot be ignored, especially in regions with high poverty rates. Despite these moral dilemmas, the team came to the conclusion that our patients have the right to be offered all available treatment options, including LDLT, and that, as a team, we must take all necessary precautions to respect donor interests and ensure donor safety. To date, we have performed 45 LDLTs and our overall surc c vival rates are comparable to other international LDLT programs, especially when the learning curve process is considered. 21c24 The rate of biliary complications in the LDLT group was significantly high when compared to DDLT, which again has been reported by other centers that perform LDLT. 23, 25 Despite this higher rate of bilic c ary and vascular complications in the LDLT group, the overall 1c, 3c, and 5cyear graft and patient survival rates are similar to the DDLT group, which reflects the succ c cessful management of those complications by a multic c disciplinary team approach.
In our early experience with LDLT at KFSHRC, we were astonished by how difficult it is to find living donors who fulfill our criteria for liver donation. Many candidates have been rejected for a variety of reasons, including unexpected pathology (steatosis and viral disease) and failure to pass psychosocial evaluation. 26 Therefore, we have come to the conclusion that LDLT is not the answer to all of our challenges, and that this procedure can help alleviate the problem of organ shortc c age, but cannot replace DDLT in Saudi Arabia. We bec c lieve that we should focus our efforts on identifying and fixing the different problems that have led to the decline in the number of available cadaveric donors. By doing so, we hope to considerably increase the cadaveric organ pool for LT in our country.
In conclusion, both DDLT and LDLT are being performed successfully at KFSHRC. The shortage of cadaveric donors and the difficulty of finding suitable donors for LDLT remain the main factors that limit expansion of our emerging LT program. Therefore, efc c forts should be directed toward increasing the number of available cadaveric donors. Until the number of cac c daver donors rises, expansion of the LDLT component of our program may be the only way to save patients from dying on the waiting list. 
